130 related articles for article (PubMed ID: 10428209)
21. Enhancement of Fas ligand-induced inhibition of neointimal formation in rabbit femoral and iliac arteries by coexpression of p35.
Luo Z; Garron T; Palasis M; Lu H; Belanger AJ; Scaria A; Vincent KA; Date T; Akita GY; Cheng SH; Barry J; Gregory RJ; Jiang C
Hum Gene Ther; 2001 Dec; 12(18):2191-202. PubMed ID: 11779403
[TBL] [Abstract][Full Text] [Related]
22. An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.
Sipo I; Hurtado Picó A; Wang X; Eberle J; Petersen I; Weger S; Poller W; Fechner H
J Mol Med (Berl); 2006 Mar; 84(3):215-25. PubMed ID: 16437213
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive imaging of apoptosis induced by adenovirus-mediated cancer gene therapy using a caspase-3 biosensor in living subjects.
Singh TD; Lee HW; Lee SW; Ha JH; Rehemtulla A; Ahn BC; Jeon YH; Lee J
Mol Imaging; 2014; 13():. PubMed ID: 25022618
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
[TBL] [Abstract][Full Text] [Related]
25. Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways.
Chen GG; Chak EC; Chun YS; Lam IK; Sin FL; Leung BC; Ng HK; Poon WS
J Lab Clin Med; 2003 Mar; 141(3):190-9. PubMed ID: 12624600
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response.
Sata M; Perlman H; Muruve DA; Silver M; Ikebe M; Libermann TA; Oettgen P; Walsh K
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1213-7. PubMed ID: 9448311
[TBL] [Abstract][Full Text] [Related]
27. Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.
Chirmule N; Moffett J; Dhagat P; Tazelaar J; Wilson JM
Hum Gene Ther; 1999 Nov; 10(17):2839-46. PubMed ID: 10584929
[TBL] [Abstract][Full Text] [Related]
28. Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer.
Zadelaar AS; von der Thüsen JH; Boesten LS; Hoeben RC; Kockx MM; Versnel MA; van Berkel TJ; Havekes LM; Biessen EA; van Vlijmen BJ
Atherosclerosis; 2005 Dec; 183(2):244-50. PubMed ID: 15927188
[TBL] [Abstract][Full Text] [Related]
29. Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.
Hyer ML; Sudarshan S; Schwartz DA; Hannun Y; Dong JY; Norris JS
Cancer Gene Ther; 2003 Apr; 10(4):330-9. PubMed ID: 12679806
[TBL] [Abstract][Full Text] [Related]
30. Bioactivities of Fas ligand-expressing retroviral particles.
Jodo S; Strehlow D; Ju ST
J Immunol; 2000 May; 164(10):5062-9. PubMed ID: 10799862
[TBL] [Abstract][Full Text] [Related]
31. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.
Chirmule N; Moscioni AD; Qian Y; Qian R; Chen Y; Wilson JM
Hum Gene Ther; 1999 Jan; 10(2):259-69. PubMed ID: 10022550
[TBL] [Abstract][Full Text] [Related]
32. Prolonged survival of pig islets xenograft by adenovirus-mediated expression of either the membrane-bound human FasL or the human decoy Fas antigen gene.
Kawamoto K; Tanemura M; Ito T; Deguchi T; Machida T; Nishida T; Doki Y; Mori M; Sawa Y
Xenotransplantation; 2008; 15(5):333-43. PubMed ID: 19134163
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
Maleniak TC; Darling JL; Lowenstein PR; Castro MG
Cancer Gene Ther; 2001 Aug; 8(8):589-98. PubMed ID: 11571537
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).
Drozdzik M; Qian C; Lasarte JJ; Bilbao R; Prieto J
Gene Ther; 1998 Dec; 5(12):1622-30. PubMed ID: 10023441
[TBL] [Abstract][Full Text] [Related]
35. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
36. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.
Hyer ML; Voelkel-Johnson C; Rubinchik S; Dong J; Norris JS
Mol Ther; 2000 Oct; 2(4):348-58. PubMed ID: 11020350
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina.
Chiou SH; Liu JH; Hsu WM; Chen SS; Chang SY; Juan LJ; Lin JC; Yang YT; Wong WW; Liu CY; Lin YS; Liu WT; Wu CW
J Immunol; 2001 Oct; 167(7):4098-103. PubMed ID: 11564832
[TBL] [Abstract][Full Text] [Related]
38. Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells.
Glaser T; Castro MG; Löwenstein PR; Weller M
Gene Ther; 2001 Mar; 8(6):469-76. PubMed ID: 11313826
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.
Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS
J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928
[TBL] [Abstract][Full Text] [Related]
40. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
